Sophie Gilbert

403 total citations
9 papers, 308 citations indexed

About

Sophie Gilbert is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Sophie Gilbert has authored 9 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Organic Chemistry. Recurrent topics in Sophie Gilbert's work include PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (2 papers) and interferon and immune responses (1 paper). Sophie Gilbert is often cited by papers focused on PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (2 papers) and interferon and immune responses (1 paper). Sophie Gilbert collaborates with scholars based in Canada. Sophie Gilbert's co-authors include Françis Rodier, Nicolas Malaquin, Marc‐Alexandre Olivier, Anne‐Marie Mes‐Masson, Eurı́dice Carmona, Diane Provencher, Hubert Fleury, Aurélie Martinez, Laudine Communal and Paloma Jara and has published in prestigious journals such as Nature Communications, Oncogene and Oncotarget.

In The Last Decade

Sophie Gilbert

7 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Gilbert Canada 6 180 128 85 63 35 9 308
Penelope D. Ruiz United States 8 306 1.7× 101 0.8× 93 1.1× 56 0.9× 28 0.8× 10 404
Hubert Fleury Canada 11 224 1.2× 99 0.8× 179 2.1× 69 1.1× 48 1.4× 13 390
Yusuke Tarumoto Japan 10 371 2.1× 66 0.5× 50 0.6× 34 0.5× 46 1.3× 32 468
Priya Hari United Kingdom 6 168 0.9× 97 0.8× 31 0.4× 84 1.3× 35 1.0× 8 283
Charlotte Beaver United Kingdom 6 184 1.0× 43 0.3× 60 0.7× 32 0.5× 34 1.0× 7 281
Enzo Tedone United States 9 278 1.5× 201 1.6× 30 0.4× 36 0.6× 49 1.4× 12 406
Timo Quante United Kingdom 7 299 1.7× 48 0.4× 82 1.0× 52 0.8× 49 1.4× 8 405
Weiwei Yi China 9 180 1.0× 43 0.3× 53 0.6× 68 1.1× 42 1.2× 13 325
Luca Melchiori United States 8 113 0.6× 124 1.0× 142 1.7× 119 1.9× 18 0.5× 13 587
Landon Wark Canada 10 206 1.1× 87 0.7× 79 0.9× 18 0.3× 46 1.3× 15 313

Countries citing papers authored by Sophie Gilbert

Since Specialization
Citations

This map shows the geographic impact of Sophie Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Gilbert more than expected).

Fields of papers citing papers by Sophie Gilbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Gilbert. The network helps show where Sophie Gilbert may publish in the future.

Co-authorship network of co-authors of Sophie Gilbert

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Gilbert. A scholar is included among the top collaborators of Sophie Gilbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Gilbert. Sophie Gilbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gilbert, Sophie, et al.. (2025). Use of activated charcoal in poisoned patients aged over than 5 year old. Canadian Journal of Emergency Medicine. 27(5). 373–380.
2.
Gilbert, Sophie, et al.. (2024). Continuous naloxone infusion for the treatment of guanfacine toxicity in a 2-year-old male. Canadian Journal of Emergency Medicine. 27(3). 223–225.
3.
Gilbert, Sophie, Benjamin Péant, Anne‐Marie Mes‐Masson, & Fred Saad. (2022). IKKε Inhibitor Amlexanox Promotes Olaparib Sensitivity through the C/EBP-β-Mediated Transcription of Rad51 in Castrate-Resistant Prostate Cancer. Cancers. 14(15). 3684–3684. 2 indexed citations
4.
Boudhraa, Zied, Kossay Zaoui, Hubert Fleury, et al.. (2021). NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer. Oncogene. 41(3). 309–320. 9 indexed citations
5.
Malaquin, Nicolas, Sophie Gilbert, Marc‐Alexandre Olivier, et al.. (2020). DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity. Cells. 9(7). 1593–1593. 41 indexed citations
7.
Fleury, Hubert, Nicolas Malaquin, Sophie Gilbert, et al.. (2019). Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence. Nature Communications. 10(1). 2556–2556. 162 indexed citations
8.
Péant, Benjamin, Sophie Gilbert, Cécile Le Page, et al.. (2016). IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression. Oncotarget. 8(9). 14487–14501. 15 indexed citations
9.
Jara, Paloma, Sophie Gilbert, Pascal Delmas, et al.. (1996). Cloning and characterization of the. Molecular and General Genetics MGG. 250(1). 97–97. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026